Clinical variables | Univariate analysis | Multiple logistic regression | |||
OR | p | OR | 95% CI | p Value | |
Age (years) | 1.09 | <0.001 | 1.07 | 1.02 to 1.12 | 0.006 |
Female subjects | 0.73 | 0.233 | |||
Smoking | 1.02 | 0.961 | |||
Hypertension | 1.27 | 0.518 | |||
Diabetes mellitus | 3.08 | 0.002 | 2.50 | 1.16 to 5.38 | 0.019 |
Coronary artery disease | 1.53 | 0.374 | |||
Atrial fibrillation | 0.84 | 0.491 | |||
NYHA>II | 1.66 | 0.052 | |||
Anaemia | 2.90 | 0.001 | 1.89 | 0.93 to 3.85 | 0.080 |
eGFR<60 mL/min/1.73 m2 | 2.57 | 0.003 | 1.64 | 0.82 to 3.27 | 0.159 |
MVA≤1.5 cm2 | 0.83 | 0.604 | |||
LVEF<50% | 2.40 | 0.007 | 2.09 | 1.05 to 4.15 | 0.036 |
RV diameter | 1.05 | 0.002 | 1.02 | 0.98 to 1.05 | 0.411 |
LVEDD index | 1.02 | 0.196 | |||
MR>8 cm2 | 1.05 | 0.843 | |||
TR volume | 1.07 | <0.001 | 1.05 | 1.01 to 1.09 | 0.021 |
Aortic valve replacement | 1.52 | 0.100 | |||
CABG | 3.23 | 0.003 | 2.96 | 1.26 to 6.93 | 0.012 |
PAP>70 mm Hg | 3.82 | <0.001 | 2.93 | 1.61 to 5.32 | <0.001 |
CABG, coronary artery bypass grafting.; eGFR, estimated glomerular filtration rate; LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; MR, mitral regurgitation; NYHA, New York Heart Association; PAP, pulmonary artery pressure; RV, right ventricle; TR, tricuspid regurgitation.